ZYME vs RCUS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 19, 2026
ZYME
RCUS
Investment Advisor Scores
RCUS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ZYME | RCUS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 20.8333 | 0 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -90.6% | -74.4% | RCUS |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 62.5/100 | 47.6/100 | ZYME |
| Profit Margin | 0.0% | 0.0% | Tie |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | BUY | HOLD | ZYME |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ZYME
MarkupPrice above SMA50, rising 50-day trend (4.4% over 20 days), RSI 61
RCUS
MarkdownPrice below a falling SMA50 (slope -6.6%), weak momentum, RSI 30
Fundamentals Snapshot
| Metric | ZYME | RCUS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 31.5 | -6.2 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.9% | -0.7% |
| Gross Margin | -2.5% | -3.2% |
| Operating Margin | -9.2% | -2.3% |
| EPS | -2.02 | -3.14 |
| Dividend Yield | — | — |